BIO CEO Warns About Government Pricing Measures at CLSA Event | BioSpace
When it comes to potential pricing controls of the pharmaceutical industry, Jim Greenwood, chief executive officer of BIO, grimly stated that “nothing good” was going on in the halls of power in Washington, D.C. Addressing a crowd of stakeholders at the California Life Sciences Association’s “An Evening with Thought Leaders,” Greenwood noted that with national […]
Connect
Follow via RSS feed or on the following social media platforms.